Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
5.23
-0.14 (-2.61%)
At close: Mar 24, 2026, 4:00 PM EDT
5.21
-0.02 (-0.38%)
After-hours: Mar 24, 2026, 7:23 PM EDT
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $129.27 million as of March 24, 2026. Its market cap has decreased by -0.71% in one year.
Market Cap
129.27M
Enterprise Value
32.20M
1-Year Change
-0.71%
Ranking
Category
Stock Price
$5.23
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $129.27M, a decrease of -26.87%. That is a compound annual growth rate of -17.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 132.73M | 26.05% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Karyopharm Therapeutics | 139.96M |
| Oramed Pharmaceuticals | 138.91M |
| Milestone Pharmaceuticals | 138.15M |
| Inhibikase Therapeutics | 135.32M |
| Spero Therapeutics | 133.52M |
| Equillium | 129.70M |
| Fate Therapeutics | 127.89M |
| Jyong Biotech | 126.20M |